Houman Javedan, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Geriatric Assessment | 10 | 2022 | 1372 | 1.270 |
Why?
|
Frail Elderly | 5 | 2021 | 693 | 1.050 |
Why?
|
Geriatrics | 3 | 2021 | 396 | 0.730 |
Why?
|
Efficiency | 1 | 2022 | 462 | 0.670 |
Why?
|
Fracture Healing | 1 | 2017 | 427 | 0.490 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 401 | 0.420 |
Why?
|
Delirium | 4 | 2020 | 1609 | 0.420 |
Why?
|
Fracture Fixation, Internal | 1 | 2017 | 917 | 0.380 |
Why?
|
Perioperative Care | 1 | 2018 | 1002 | 0.370 |
Why?
|
Quality Improvement | 3 | 2021 | 3749 | 0.350 |
Why?
|
Hip Fractures | 2 | 2014 | 955 | 0.330 |
Why?
|
Anesthesiology | 2 | 2019 | 1060 | 0.330 |
Why?
|
Preoperative Care | 3 | 2019 | 2250 | 0.240 |
Why?
|
Traumatology | 2 | 2021 | 88 | 0.220 |
Why?
|
Postoperative Complications | 4 | 2018 | 15295 | 0.200 |
Why?
|
Holistic Health | 1 | 2021 | 47 | 0.200 |
Why?
|
Trauma Centers | 2 | 2017 | 890 | 0.200 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1832 | 0.160 |
Why?
|
Dura Mater | 1 | 2020 | 291 | 0.160 |
Why?
|
Proxy | 1 | 2019 | 144 | 0.160 |
Why?
|
Aged, 80 and over | 13 | 2022 | 57776 | 0.150 |
Why?
|
Fractures, Bone | 2 | 2021 | 1947 | 0.150 |
Why?
|
Risk Assessment | 5 | 2020 | 23338 | 0.140 |
Why?
|
Musculoskeletal System | 1 | 2019 | 175 | 0.140 |
Why?
|
Sarcopenia | 1 | 2021 | 368 | 0.140 |
Why?
|
Disease Management | 2 | 2019 | 2459 | 0.130 |
Why?
|
Aged | 19 | 2022 | 163280 | 0.130 |
Why?
|
Laminectomy | 1 | 2016 | 234 | 0.130 |
Why?
|
Program Development | 1 | 2021 | 1316 | 0.130 |
Why?
|
Length of Stay | 5 | 2020 | 6309 | 0.120 |
Why?
|
Mass Screening | 2 | 2019 | 5255 | 0.110 |
Why?
|
Patients | 1 | 2019 | 900 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1580 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2021 | 5078 | 0.100 |
Why?
|
Decompression, Surgical | 1 | 2016 | 594 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1439 | 0.100 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1462 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1458 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 921 | 0.090 |
Why?
|
Accidental Falls | 1 | 2017 | 1062 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2002 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2531 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2017 | 6365 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2022 | 3528 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1288 | 0.070 |
Why?
|
Decision Making | 2 | 2021 | 3887 | 0.070 |
Why?
|
Patient Readmission | 2 | 2017 | 3114 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3610 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2017 | 4043 | 0.060 |
Why?
|
Humans | 23 | 2022 | 744343 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15076 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6770 | 0.060 |
Why?
|
Male | 12 | 2021 | 350118 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.060 |
Why?
|
Pain | 1 | 2019 | 4986 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2400 | 0.060 |
Why?
|
Prognosis | 3 | 2018 | 29063 | 0.060 |
Why?
|
Female | 11 | 2021 | 380194 | 0.050 |
Why?
|
Gamma Cameras | 1 | 2002 | 36 | 0.050 |
Why?
|
Erythema | 1 | 2003 | 257 | 0.050 |
Why?
|
Thyroglobulin | 1 | 2002 | 114 | 0.050 |
Why?
|
Skin Pigmentation | 1 | 2003 | 282 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 40561 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2003 | 486 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2003 | 1060 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 361 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2002 | 1032 | 0.040 |
Why?
|
Inappropriate Prescribing | 1 | 2020 | 202 | 0.040 |
Why?
|
Age Factors | 3 | 2020 | 18370 | 0.040 |
Why?
|
Polypharmacy | 1 | 2020 | 294 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 481 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 392 | 0.040 |
Why?
|
Prospective Studies | 5 | 2019 | 53288 | 0.030 |
Why?
|
Inservice Training | 1 | 2019 | 392 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1681 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2017 | 63114 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1769 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 77449 | 0.030 |
Why?
|
Body Composition | 1 | 2021 | 2401 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2002 | 2645 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1848 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.020 |
Why?
|
Hospitalization | 2 | 2022 | 10262 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2418 | 0.020 |
Why?
|
Terminal Care | 1 | 2021 | 1694 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2002 | 2282 | 0.020 |
Why?
|
Patient Admission | 1 | 2016 | 1380 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2014 | 1462 | 0.020 |
Why?
|
Palliative Care | 1 | 2021 | 3493 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8663 | 0.020 |
Why?
|
Health Personnel | 1 | 2019 | 3218 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 6993 | 0.020 |
Why?
|
Exercise | 1 | 2020 | 5615 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3679 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5317 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 876 | 0.010 |
Why?
|
Melanins | 1 | 2003 | 289 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
Adenoma, Oxyphilic | 1 | 2002 | 143 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12804 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.010 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2002 | 324 | 0.010 |
Why?
|
Thyroxine | 1 | 2002 | 667 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9583 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 783 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2002 | 4851 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4364 | 0.010 |
Why?
|
Middle Aged | 1 | 2002 | 213383 | 0.000 |
Why?
|